Freeline Therapeutics (FRLN) Short Interest Ratio & Short Volume → What President Biden's new law means for investors (From Stansberry Research) (Ad) Free FRLN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial Media Freeline Therapeutics Short Interest DataCurrent Short Interest23,900 sharesPrevious Short Interest28,300 sharesChange Vs. Previous Month-15.55%Dollar Volume Sold Short$153,916.00Short Interest Ratio0.6 Days to CoverLast Record DateJanuary 31, 2024Outstanding Shares4,340,000 sharesFloat Size4,140,000 sharesShort Percent of Float0.58%Today's Trading Volume0 sharesAverage Trading Volume12,055 sharesToday's Volume Vs. Average0% Short Selling Freeline Therapeutics ? Sign up to receive the latest short interest report for Freeline Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFRLN Short Interest Over TimeFRLN Days to Cover Over TimeFRLN Percentage of Float Shorted Over Time Ad Stansberry ResearchWhat President Biden's new law means for investorsWhat's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. Freeline Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202423,900 shares $153,916.00 -15.6%0.6%0.6 $6.44 1/15/202428,300 shares $180,837.00 -41.0%0.7%0.6 $6.39 12/31/202348,000 shares $305,760.00 -6.6%1.2%0.7 $6.37 12/15/202351,400 shares $332,044.00 -35.4%1.2%0.2 $6.46 11/30/202379,500 shares $501,645.00 -21.8%1.9%0.4 $6.31 11/15/2023101,700 shares $492,228.00 -28.5%2.5%0.5 $4.84 Get the Latest News and Ratings for FRLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Freeline Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2023142,300 shares $712,923.00 -46.8%3.4%0.7 $5.01 10/15/2023267,500 shares $971,025.00 +164.9%6.5%1.3 $3.63 9/30/2023101,000 shares $434,300.00 -2.2%2.4%0.2 $4.30 9/15/2023103,300 shares $387,375.00 -2.5%2.5%0.3 $3.75 8/31/2023105,900 shares $379,122.00 -17.1%2.6%0.3 $3.58 8/15/2023127,800 shares $493,308.00 +22.3%3.1%0.3 $3.86 7/31/2023104,500 shares $379,335.00 -69.7%2.5%0.2 $3.63 7/15/2023345,200 shares $1.94 million +1,164.5%8.4%0.8 $5.63 6/30/202327,300 shares $70,434.00 -50.7%0.7%0.1 $2.58 6/15/202355,400 shares $148,472.00 +93.7%1.3%0.5 $2.68 5/31/202328,600 shares $71,786.00 +271.4%0.7%0.3 $2.51 5/15/20237,700 shares $25,641.00 No Change0.2%0.1 $3.33 10/31/2022147,500 shares $107,674.85 +7.8%N/A4.6 $0.73 10/15/2022136,800 shares $90,288.00 -2.5%N/A3.4 $0.66 9/30/2022140,300 shares $98,210.00 -10.2%N/A2.2 $0.70 9/15/2022156,200 shares $133,051.16 -3.4%N/A2 $0.85 8/31/2022161,700 shares $137,364.15 -1.6%N/A2 $0.85 8/15/2022164,300 shares $161,014.00 -27.9%N/A2 $0.98 7/31/2022227,800 shares $202,742.00 +11.4%N/A2.7 $0.89 7/15/2022204,500 shares $156,912.85 -3.4%N/A2.2 $0.77 6/30/2022211,700 shares $184,179.00 -7.8%N/A1.6 $0.87 6/15/2022229,500 shares $189,314.55 -15.1%N/A1.2 $0.82 5/31/2022270,300 shares $208,103.97 +11.8%N/A1.4 $0.77 5/15/2022241,700 shares $181,275.00 -18.3%1.0%1.2 $0.75 4/30/2022295,700 shares $266,159.57 +8.5%2.5%1.4 $0.90 4/15/2022272,600 shares $278,052.00 -20.9%2.3%1.1 $1.02 3/31/2022344,400 shares $385,728.00 +41.4%N/A1.1 $1.12 3/15/2022243,500 shares $227,185.50 +2.2%0.7%0.3 $0.93 2/28/2022238,200 shares $252,492.00 +3.2%0.7%0.3 $1.06 2/15/2022230,800 shares $281,576.00 -7.5%0.7%0.3 $1.22 1/31/2022249,600 shares $309,504.00 -20.3%0.8%0.3 $1.24 1/15/2022313,300 shares $460,551.00 +249.7%N/A0.3 $1.47 12/31/202189,600 shares $177,408.00 +93.1%0.3%0.1 $1.98 12/15/202146,400 shares $100,688.00 +16.3%0.1%0.5 $2.17What President Biden's new law means for investors (Ad)What's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. 11/30/202139,900 shares $92,568.00 -8.9%0.1%0.3 $2.32 11/15/202143,800 shares $130,524.00 -33.3%0.1%0.3 $2.98 10/29/202165,700 shares $195,786.00 +3.0%0.2%0.2 $2.98 10/15/202163,800 shares $204,798.00 -15.2%0.2%0.2 $3.21 9/30/202175,200 shares $256,432.00 +5.0%0.2%0.2 $3.41 9/15/202171,600 shares $284,252.00 -7.1%0.2%0.2 $3.97 8/31/202177,100 shares $296,835.00 -18.2%0.2%0.2 $3.85 8/13/202194,200 shares $312,744.00 +3.3%0.3%0.2 $3.32 7/30/202191,200 shares $434,112.00 +165.1%0.3%0.4 $4.76 7/15/202134,400 shares $227,384.00 -37.3%0.1%0.3 $6.61 6/30/202154,900 shares $447,435.00 +10.9%0.2%1.6 $8.15 6/15/202149,500 shares $470,745.00 -24.2%0.2%1.6 $9.51 5/28/202165,300 shares $718,300.00 +25.6%0.2%2.4 $11.00 5/14/202152,000 shares $455,000.00 +83.8%0.2%4.3 $8.75 4/30/202128,300 shares $332,808.00 -5.0%0.1%2.7 $11.76 4/15/202129,800 shares $359,090.00 +1.0%N/A0 $12.05 3/31/202129,500 shares $392,055.00 -9.0%0.1%3.3 $13.29 3/15/202132,400 shares $456,516.00 +7.3%0.1%3.4 $14.09 2/26/202130,200 shares $456,926.00 +6.3%0.1%2.5 $15.13 2/12/202128,400 shares $429,408.00 -8.4%0.1%2.3 $15.12 1/29/202131,000 shares $550,246.90 -61.1%0.1%2.1 $17.75 1/15/202179,700 shares $1.43 million No Change0.2%4.9 $18.00 FRLN Short Interest - Frequently Asked Questions What is Freeline Therapeutics' current short interest? Short interest is the volume of Freeline Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 23,900 shares of FRLN short. 0.58% of Freeline Therapeutics' shares are currently sold short. Learn More on Freeline Therapeutics' current short interest. What is a good short interest ratio for Freeline Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FRLN shares currently have a short interest ratio of 1.0. Learn More on Freeline Therapeutics's short interest ratio. What is a good short interest percentage for Freeline Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of Freeline Therapeutics' floating shares are currently sold short. Is Freeline Therapeutics' short interest increasing or decreasing? Freeline Therapeutics saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 23,900 shares, a drop of 15.5% from the previous total of 28,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Freeline Therapeutics' float size? Freeline Therapeutics currently has issued a total of 4,340,000 shares. Some of Freeline Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Freeline Therapeutics currently has a public float of 4,140,000 shares. How does Freeline Therapeutics' short interest compare to its competitors? 0.58% of Freeline Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Freeline Therapeutics: LianBio (0.36%), PHAXIAM Therapeutics S.A. (0.01%), DURECT Co. (3.24%), Lipocine Inc. (3.49%), Inspira Technologies Oxy B.H.N. Ltd. (1.06%), Evogene Ltd. (0.24%), SeaStar Medical Holding Co. (3.85%), Enlivex Therapeutics Ltd. (1.42%), CareCloud, Inc. (0.98%), Spectral AI, Inc. (3.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Freeline Therapeutics stock? Short selling FRLN is an investing strategy that aims to generate trading profit from Freeline Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Freeline Therapeutics? A short squeeze for Freeline Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FRLN, which in turn drives the price of the stock up even further. How often is Freeline Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FRLN, twice per month. The most recent reporting period available is January, 31 2024. More Short Interest Resources from MarketBeat Related Companies: LIAN Short Interest Data PHXM Short Interest Data DRRX Short Interest Data LPCN Short Interest Data IINN Short Interest Data EVGN Short Interest Data ICU Short Interest Data ENLV Short Interest Data CCLD Short Interest Data MDAI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FRLN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsDigitizing the $11T commodities sector with one tiny stockResource Stock Digest